Shield Therapeutics plc

Company Profile

Company website
Pharmaceuticals & Biotechnology (Pharmaceuticals)

Shield Therapeutics plc (AIM: STX) is a de-risked, commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals that addresses patients' unmet medical needs, with an initial focus on addressing iron deficiency anaemia in adults with its approved product Feraccru®/Accrufer®. 

Investor Access

01 Feb
Event information
Click here to watch Shield Therapeutics plc’s latest investor presentation on the digital platform Investor Meet Company.
Financial Calendar
 Event  Date
Year End 31 December
Half  Year End 30 June
Preliminary Results* May
Interim Results* September
AGM* June

* Months based on previous announcements of this kind